Stanley Sher of Washington, D.C. was diagnosed with an aggressive form of melanoma in 2013. After several failed treatments and surgeries, he sought treatment at MedStar Georgetown University Hospital where he enrolled in a clinical trial of an immunotherapy combination through Georgetown University’s Lombardi Comprehensive Cancer Center. Within weeks his melanoma began to shrink. By 2015 he was cancer-free. The study regimen is now FDA approved for metastatic melanoma.

Watch the journey he calls miraculous.

Special thanks MedStar Georgetown University Hospital

[responsive_video link=”https://youtu.be/6N5iDi5UlMI”]